期刊
ANTIVIRAL RESEARCH
卷 92, 期 2, 页码 359-363出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.antiviral.2011.07.017
关键词
DNA vaccine; FMDV; ScFv; T-cell; Neutralizing antibody
资金
- Fundacion Ramon Areces
- EU Network EPIZONE
- Spanish Government [13]
- [BIO2008-0447-C03-01]
- [AGL2007-66441-C03-01]
- [AGL2010-22229-C03-01]
- [CSD2006-00007]
Development of efficient and safer vaccines against foot-and-mouth disease virus (FMDV) is a must. Previous results obtained in our laboratory have demonstrated that DNA vaccines encoding B and T cell epitopes from type C FMDV, efficiently controlled virus replication in mice, while they did not protect against FMDV challenge in pigs, one of the FMDV natural hosts. The main finding of this work is the ability to improve the protection afforded in swine using a new DNA-vaccine prototype (pCMV-APCH1BTT). encoding FMDV B and T-cell epitopes fused to the single-chain variable fragment of the 1F12 mouse monoclonal antibody that recognizes Class-II Swine Leukocyte antigens. Half of the DNA-immunized pigs were fully protected upon viral challenge, while the remaining animals were partially protected, showing a delayed, shorter and milder disease than control pigs. Full protection in a given vaccinated-pig correlated with the induction of specific IFN gamma-secreting T-cells, detectable prior to FMDV-challenge, together with a rapid development of neutralizing antibodies after viral challenge, pointing towards the relevance that both arms of the immune response can play in protection. Our results open new avenues for developing future FMDV subunit vaccines. (C) 2011 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据